Carly Baltare, PA
Physician Assistant · Broomfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Intermountain Medical Group Denver LLC · 571 clinicians in this group
Hospitals listed: Intermountain Health Saint Joseph Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Carly Baltare’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Colorado PA.6853Physician assistant · since 2021 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Saint Joseph HospitalDenver, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.119, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.507, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.19, Oct 2024 – Sep 2025
See every measure and the patient survey for Saint Joseph Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.119 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.507 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.19 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.14 to 2.15) · 437 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.67 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 104 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,837 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,022 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,276 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.07 (0.76 to 5.38) · 702 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.87) · 413 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.58 to 3.68) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.53 (0 to 13.11) · 366 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.34 (0.71 to 7.97) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 150 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.28 (0.39 to 2.18) · 1,660 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 83 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.337 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.778 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 563 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.8 · 125 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 122 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 398 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 8.2) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (7.6 to 15.8) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.4 to 17.5) · 48 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 147 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,155 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
Original Medicare doctor bills
$11,083
Medicare paid this office $11,083 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 37 | $2,965 | $74 |
| New patient visit (45+ min) | 24 | $2,381 | $99 |
| Short return visit (20+ min) | 26 | $1,425 | $48 |
| New patient visit (30+ min) | 21 | $1,294 | $62 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1,207 | $50 |
See all 6 services
| Return visit (30+ min) | 37 | $2,965 | $74 |
| New patient visit (45+ min) | 24 | $2,381 | $99 |
| Short return visit (20+ min) | 26 | $1,425 | $48 |
| New patient visit (30+ min) | 21 | $1,294 | $62 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1,207 | $50 |
| Automated urinalysis test | 25 | $55 | $2 |
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 75 · Women 74% · Health risk score 1.01. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 65% · Coronary heart disease 22% · Chronic kidney disease 21% · Depression 20% · Diabetes 17% · Atrial fibrillation 15% · Cancer 10% · COPD 10%.
The office billed $35,341, Medicare allowed $15,432 and paid $11,083; for 230 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 230 | 75 | 1.01 | $35,341 | $11,083 |
| 2023 | 57 | 130 | 72 | 0.94 | $18,631 | $6,925 |
| 2022 | 167 | 359 | 74 | 0.95 | $47,639 | $21,063 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 25 | $1,893 | $73 |
| New patient visit (45+ min) | 14 | $1,311 | $94 |
| New patient visit (30+ min) | 12 | $955 | $80 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 15 | $754 | $50 |
2022: 6 services
| New patient visit (45+ min) | 45 | $4,794 | $107 |
| Return visit (30+ min) | 48 | $4,170 | $83 |
| New patient visit (30+ min) | 45 | $3,913 | $87 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 56 | $2,981 | $51 |
| Short return visit (20+ min) | 35 | $2,781 | $75 |
| Automated urinalysis test | 24 | $53 | $2 |
Medicaid work
$5,571 in 2023
Medicaid paid $5,571 for 204 billed services this clinician did in 2023, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 31 | $2,928 |
| New patient visit (45+ min) | 19 | $2,375 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 18 | $268 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 23 | $0 |
| Services provided in an urgent care center (list in addition to code for service) | 113 | $0 |
| 2023 | 204 | 5 | 35 | $5,571 |
| 2022 | 957 | 9 | 53 | $22,254 |
See the largest Medicaid services in earlier years
2022
| New patient visit (45+ min) | 38 | $4,670 |
| Return visit (30+ min) | 57 | $4,514 |
| New patient visit (30+ min) | 51 | $4,333 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 97 | $4,188 |
| Short return visit (20+ min) | 51 | $3,147 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 23 | $1,341 |
| Services provided in an urgent care center (list in addition to code for service) | 384 | $62 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 138 | $0 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 118 | $0 |
Drugs they prescribed that Part D paid
$3,127
Pharmacies billed $3,127 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 121) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
108 generic and fewer than 11 brand-name prescriptions · $3,127 in drug cost · 78 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin | 24 | $59 | $2 |
Year by year
| 2024 | 121 | 98 | 0% (0) | None | $3,127 |
| 2023 | 57 | 48 | 0% (0) | None | $658 |
| 2022 | 140 | 105 | 0% (0) | 11% | $2,854 |
| 2021 | 23 | 16 | 0% (0) | None | $197 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 3 drugs
| Nitrofurantoin Mono-Macro | 19 | $292 | $15 |
| Doxycycline Hyclate | 15 | $177 | $12 |
| Azithromycin | 12 | $111 | $9 |
Money from drug and device companies
$30 in 2022
| 2022 | 2 | 2 | None | $30 |
| 2021 | 5 | 7 | None | $75 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine Biosciences | Ongentys | $16 | 1 payment
|
| Genentech USA | Xofluza | $14 | 1 payment
|
See all 2 published payments
| Neurocrine Biosciences | Meals · 2022-03-29 | Ongentys | $16 |
| Genentech USA | Meals · 2022-01-19 | Xofluza | $14 |
See earlier years (2021)
2021: $75
| Neurocrine Biosciences | Ingrezza | $28 | 2 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $13 | 1 payment
|
| Aprecia Pharmaceuticals | Spritam | $13 | 1 payment
|
| AbbVie | Ubrelvy | $13 | 1 payment
|
| Genentech USA | Xofluza | $8 | 2 payments
|
Professional record
- NPI
- 1326696006
- Licence
- CO PA.0006853Colorado PA.6853: Active
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Student in a training program (390200000X)
- Mailing address
- 8006 E Arapahoe Rd # 100, Centennial, CO, 80112
- NPI first listed
- 2019-08-27
- NPI last updated
- 2022-09-22
- NPI record certified
- 2022-09-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2446 Johnson Pl, Santa Clara, CA, 95050